AOD-9604 research guide

AOD-9604 in Sadamitsu — Fat Loss Peptide Research Guide

AOD-9604 research guide for Sadamitsu. HGH fragment studied for fat metabolism — covers mechanism, purity standards, COA verification, and how to source AOD-9604.

Skip to Sourcing Guide Order AOD-9604 →

AOD-9604 in Sadamitsu — Research & Sourcing Guide

Most researchers searching for AOD-9604 in Sadamitsu rapidly learn that local retail options are essentially nonexistent. What this means for Sadamitsu researchers is that your location matters far less than your ability to evaluate vendor quality — and those evaluation tools are available to every researcher. What reliably differentiates top AOD-9604 vendors is complete batch-specific analytical documentation: HPLC for purity, mass spec for molecular identity verification, and endotoxin testing for safety documentation. Use this guide to evaluate AOD-9604 vendors rigorously — the framework here apply whether you are in Sadamitsu or anywhere else.

What Studies Say About AOD-9604

CJC-1295 with DAC (Drug Affinity Complex) is a GHRH analogue with an extended half-life achieved through DAC technology that enables covalent binding to albumin. This modification extends the half-life from minutes (for native GHRH) to approximately 6-8 days, creating a sustained elevation in basal GH levels rather than the pulsatile pattern produced by GHRP compounds. This pharmacokinetic distinction is significant for research design: AOD-9604 based on CJC-1295 with DAC produces a different GH secretion pattern than GHRP compounds, with different downstream effects on IGF-1 and protein synthesis. Researchers in Sadamitsu comparing compounds in this class should account for these pharmacokinetic differences in their experimental design.

AOD-9604 Purchasing Guide

Quality AOD-9604 sourcing begins with a simple filter: does this vendor publish batch-specific COAs proactively? Suppliers that publish proactively are demonstrating research-grade standards. Mass spectrometry in the COA verifies that the main HPLC peak is actually AOD-9604 and not another compound with similar chromatographic behaviour — HPLC purity alone provides no identity confirmation. For Sadamitsu researchers evaluating new suppliers: a small initial order to verify quality before committing to research quantities is what experienced peptide researchers consistently do. Bacteriostatic water is the correct reconstitution medium for AOD-9604 — it contains 0.9% benzyl alcohol that suppresses bacterial proliferation and extends reconstituted shelf life to 4 weeks when kept refrigerated.

Order AOD-9604 — ships to Sadamitsu
COA-verified · International tracking · Research grade
Order Now →

AOD-9604 Research Safety Guide

AOD-9604 is available for research use only and is not approved for human consumption by the FDA or equivalent regulatory bodies — all information here is educational. Reconstitute AOD-9604 with bacteriostatic water at the concentration suited to your research design; a standard 5mg reconstituted in 2mL produces 2.5mg/mL — or 25mcg per insulin syringe unit. Endotoxin testing in the AOD-9604 COA is not optional — gram-negative bacterial endotoxins can trigger dangerous immune responses at very low concentrations, and no discount compensates for this missing data. PubMed and bioRxiv provide the most complete literature coverage for AOD-9604 research; prioritise peer-reviewed studies with characterised source material over conference abstracts or single case observations.

Frequently Asked Questions

How does AOD-9604 differ from growth hormone?

AOD-9604 contains only the fat-metabolism-relevant fragment of growth hormone (the C-terminal region) without the IGF-1-stimulating N-terminal domain. This means it targets fat cells' beta-adrenergic receptors for lipolytic effects without producing the anabolic IGF-1 signaling associated with full-length GH.

What is the clinical trial history of AOD-9604?

AOD-9604 has undergone multiple Phase II clinical trials for obesity treatment by Metabolic Pharmaceuticals in Australia. The trials showed safety and tolerability but mixed efficacy results for weight loss. It holds GRAS (Generally Recognized As Safe) status from the FDA for food use, which is unusual for research peptides.

What is AOD-9604?

AOD-9604 is a synthetic peptide analogue of the C-terminal fragment of human growth hormone (amino acids 177-191), with an additional tyrosine residue at the N-terminus. It has been studied for fat metabolism effects, specifically lipolysis stimulation and lipogenesis inhibition, without the IGF-1-stimulating effects of full-length GH. It has undergone clinical trials for obesity treatment.

Order AOD-9604 today
COA-verified · International shipping available
Order Now →